|

Clinical Study Evaluating Outcomes of Reverse Shoulder Arthroplasty With SMR Stemless

RECRUITINGSponsored by Arthro Medics AG
Actively Recruiting
SponsorArthro Medics AG
Started2016-11-22
Est. completion2024-08-30
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04529798

Summary

The objectives of this study are the assessment of the clinical, radiographical and patient-reported outcomes of SMR Stemless Reverse Shoulder Arthroplasty (LimaCorporate S.p.A.) used as standard of care over a period of at least 2 years of follow-up and the evaluation of the incidence of any complication.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* rotator-cuff arthropathy, osteoarthritis
* approving written informed consent

Exclusion Criteria:

* Female patients who are pregnant, nursing, or planning a pregnancy.
* All adult patients with any of the SMR Stemless contraindication for use for the reverse configuration as reported in the current local Instruction for use.
* not consenting in participating in this study

Conditions3

ArthritisOsteo Arthritis ShouldersRotator Cuff Tear Arthropathy

Browse More Trials

Arthritis trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.